申请人:ERASCA INC
公开号:WO2022266206A1
公开(公告)日:2022-12-22
The present application provides conjugates of protein-binding ligands, in particular G12D mutant KRAS ligands, with ubiquitin ligase ligands and methods for treating diseases such as cancer.
本申请提供了蛋白质结合
配体的共轭物,尤其是G12D突变KRAS
配体与泛素连接酶
配体,并提供了用于治疗癌症等疾病的方法。